In preclinical research, scientific expertise alone is not enough. The reliability of results depends on a solid foundation of standardized processes, strict protocols, and internationally recognized certifications. This is where accreditations play a critical role.

Contract Research Organizations (CROs) must operate under the highest global standards to ensure that every study meets rigorous requirements for validity, reproducibility, and safety. These standards are not optional. They are essential to generating data that regulators, partners, and patients can trust.

At Versa Biomedical, this commitment is reflected in our triple certification framework:

• ISO 13485 – Quality management systems for medical devices
• ISO 9001 – Organization-wide quality management
• GLP (Good Laboratory Practices) – Ensuring regulatory-compliant, safe, and reproducible research

Together, these certifications ensure consistency, traceability, and scientific rigor across every project.

Certifications are not bureaucracy, they are the foundation of trust. They guarantee that every partner can rely on both the process and its outcomes.

You can explore our full accreditation framework here:
https://versabiomedical.com/about-us/accreditations/

At Versa Biomedical, being triple certified and fully FDA compliant is not just a milestone, it is a clear demonstration of our commitment to excellence and our role as a trusted partner for global biomedical innovation.

Because true innovation requires both openness and rigor.
Open models. Open futures.